1. CAR T‐CELLS ARE ARRIVING. IS ALLOGENEIC TRANSPLANT AN OBSOLETE APPROACH FOR DE NOVO/TRANSFORMED DLBCL IN THE CAR T‐CELLS ERA? LONG‐TERM FOLLOW‐UP OF A SINGLE CENTRE UNIT. (12th June 2019) Authors: Prieto‐García, L.; Alcoceba, M.; Pérez‐López, E.; López‐Corral, L.; Delgado, M.; Sánchez‐Guijo, F.; Martín, A.; Navarro‐Bailón, A.; Baile, M.; López‐Parra, M.; Tamayo, P.; Gutiérrez, N.C.; Vázquez, L.; Cabrero, M.; Martín, A.; Caballero, D. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 508 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Initial management of primary central nervous system lymphoma in Spain in the last decade. The experience of the GELTAMO and Spanish neuro‐oncology groups. (June 2017) Authors: Mercadal, S.; Vidal, N.; López‐Parra, M.; Ibañez, M.; Caldú, R.; Bobillo, S.; Barceló, I.; García, E.; Martinez, P.; Cacabelos, P.; Dlouhy, I.; Sancho, J.; Muntañola, A.; Gómez, L.; Erro, E.; Gállego, J.; Salar, A.; Caballero, A.; Solé, M.; Huertas, N. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 354 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗